Concepedia

Ping Yan

PY

Statistics

Publications

40

Citations

3.3K

H-Index

26

Active since

2010

Affiliations

Second Xiangya Hospital of Central South University(Current)

Central South University

Fudan University

Sichuan University

Jiangsu Hengrui Medicine (China)

Ping Yan is an author at Second Xiangya Hospital of Central South University specializing in medicine, pharmacology, and nephrology.

Publications per year

2010–2023

40

Publications

40

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Richard M. Bergenstal, Carol Wysham, Leigh MacConell et al. · The Lancet · 2010 · 605 citations

Medicine, Pharmacology, Pharmacotherapy +15

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes

Thomas Blevins, John Pullman, Jaret Malloy et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 446 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · The Lancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10

Panorama: A Targeted Proteomics Knowledge Base

Vagisha Sharma, Josh Eckels, Greg Taylor et al. · Journal of Proteome Research · 2014 · 233 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +17

Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial

Binghe Xu, Qingyuan Zhang, Pin Zhang et al. · Nature Medicine · 2021 · 169 citations

Medicine, Oncology, Pharmacology +12

1–5 of 40